Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Antares Pharma Inc (NASDAQ:ATRS)

1.22
Delayed Data
As of Aug 31
 -0.04 / -3.17%
Today’s Change
0.67
Today|||52-Week Range
2.03
+0.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues11.1M11.8M12.3M12.2M
 
 
 
 
 
Cost of Goods Sold4.7M5.6M6.4M6.8M
 
 
 
 
 
Depreciation And Amortization400.8K400.1K413.5K477.8K
 
 
 
 
 
 
Operating ExpensesGross Income6.0M5.8M5.5M4.9M
 
 
 
 
 
General Expenses11.8M12.3M13.3M11.0M
 
 
 
 
 
Research And Development5.1M5.6M5.6M3.9M
 
 
 
 
 
Total Operating Expenses16.9M18.3M20.0M18.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.8M-6.5M-7.7M-6.1M
 
 
 
 
 
Other Expenses29.5K39.0K52.1K-9.2K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.7M-6.5M-7.7M-6.1M
 
 
 
 
 
Income Taxes0.00-175.0K0.000.00
 
 
Net Income-5.7M-6.6M-7.7M-6.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS154.8M154.8M154.9M154.9M
 
 
 
 
 
Shares To Calculate EPS Diluted154.8M154.8M154.9M154.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.04-$0.04-$0.05-$0.04
 
 
 
 
 
EPS Diluted-$0.04-$0.04-$0.05-$0.04